Patents by Inventor Alfred Luitjens

Alfred Luitjens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the production of adenoviral vectors
    Patent number: 10041049
    Abstract: The invention provides methods for large-scale production of recombinant adenovirus 35, using perfusion systems and infection at very high-cell densities.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: August 7, 2018
    Assignee: Janssen Vaccines & Prevention B.V.
    Inventors: Alfred Luitjens, John A. Lewis
  • METHOD FOR THE PRODUCTION OF AD26 ADENOVIRAL VECTORS
    Publication number: 20180080010
    Abstract: Described are methods for large-scale production of recombinant adenovirus 26, utilizing perfusion systems and infection at very high cell densities.
    Type: Application
    Filed: November 27, 2017
    Publication date: March 22, 2018
    Applicant: Janssen Vaccines & Prevention B.V.
    Inventors: Herman Van Herk, Alfred Luitjens
  • METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS
    Publication number: 20120315696
    Abstract: Described are methods for large-scale production of recombinant adenovirus 26, utilizing perfusion systems and infection at very high cell densities.
    Type: Application
    Filed: February 14, 2011
    Publication date: December 13, 2012
    Inventors: Alfred Luitjens, Herman Van Herk
  • METHOD FOR THE PRODUCTION OF ADENOVIRAL VECTORS
    Publication number: 20110207202
    Abstract: The invention provides methods for large-scale production of recombinant adenovirus 35, using perfusion systems and infection at very high-cell densities.
    Type: Application
    Filed: October 29, 2009
    Publication date: August 25, 2011
    Inventors: Alfred Luitjens, John Alfred Lewis